Association Between Hemoglobin-Albumin-Lymphocyte-Platelet Index and Mortality in Hospitalized COVID-19 Omicron BA.2 Infected Patients
Wei Wu,Wenbin Lu,Dongmei Hong,Xiya Yu,Lize Xiong
DOI: https://doi.org/10.2147/idr.s451613
2024-04-12
Infection and Drug Resistance
Abstract:Wei Wu, 1– 4, &ast Wenbin Lu, 5, &ast Dongmei Hong, 1– 4 Xiya Yu, 1– 4 Lize Xiong 1– 4 1 Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Shanghai, 200434, People's Republic of China; 2 Department of Anesthesiology and Perioperative Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, People's Republic of China; 3 Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, People's Republic of China; 4 Clinical Research Centre for Anesthesiology and Perioperative Medicine, Tongji University, Shanghai, 200434, People's Republic of China; 5 Faculty of Anesthesiology, Changhai Hospital, Naval Medical University/Second Military Medical University, PLA, Shanghai, 200433, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiya Yu; Lize Xiong, Tel +86-21-55603999 ; +86-21-55603002, Fax +86-21-56660851, Email ; ; Background: The hemoglobin-albumin-lymphocyte-platelet (HALP) index is a novel biomarker reflecting systemic inflammation and nutritional status which are important for coronavirus disease 2019 (COVID-19) mortality. However, the association between HALP and mortality in patients with COVID-19 has yet to be investigated. Methods: A cohort of COVID-19 Omicron BA.2 infected patients admitted to the Shanghai Fourth People's Hospital, School of Medicine, Tongji University from April 12, 2022 to June 17, 2022 was retrospectively analyzed. Laboratory examinations on hospital admission, including hemoglobin, albumin, and lymphocyte and platelet, were collected. The association between baseline HALP and in-hospital poor overall survival (OS) was assessed using Kaplan–Meier curves, Cox regression models, interaction, and stratified analyses. Results: A total of 2147 patients with COVID-19 Omicron BA.2 infection were included in the final analyses, and mortality in the hospital was 2.65%. Multivariate analysis indicated that low HALP index was independently associated with in-hospital mortality of COVID-19 patients [hazard ratio (HR) = 2.08; 95% confidence interval (CI) = 1.17– 3.73]. Subgroup analysis demonstrated that low HALP index was an independent risk factor for in-hospital mortality in COVID-19 patients with age ≥ 70 (HR = 2.22, CI = 1.18– 4.15) and severe cases (HR = 2.09, CI = 1.13– 3.86). Conclusion: HALP index is independently related to in-hospital poor OS for COVID-19 Omicron BA.2 infected patients, especially for age ≥ 70 and severe cases. HALP index on hospital admission is a useful candidate biomarker for identifying high risk of mortality in COVID-19 Omicron BA.2 infected patients. Keywords: biomarkers, COVID-19, hemoglobin-albumin-lymphocyte-platelet index, mortality, Omicron BA.2 Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2 has aroused emerging global concerns. 1–3 Although there have been major advances in treatment modalities and large-scale vaccination campaigns, patients with severe or critically severe COVID-19 are still prone to a poor prognosis. Previous studies have shown that patients with severe and critically severe COVID-19 were difficult to treat and had a high mortality rate, even in intensive care unit (ICU). 4,5 In addition, early detection of severely infected COVID-19 patients was important to identify patients with poor prognosis. 6 Therefore, it is crucial to quickly identify risk factors that can predict patient prognosis and make decisions for subsequent treatments in COVID-19 Omicron BA.2 infected patients, especially for severely infected COVID-19 patients. A large number of studies have shown that laboratory markers had an important role in the diagnosis, prognosis, and mortality of COVID-19. 7–11 Inflammation and nutritional status are also important for COVID-19 mortality. Previous studies have shown that systemic inflammatory biomarkers based on peripheral blood cells, such as derived neutrophil-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index were reported to predict the prognosis of COVID-19 patients. 12–14 In addition, nutritional status, such as hemoglobin and albumin levels, has also been shown to be the useful indicators related to the prognosis of patients with moderate-to-severe COVID-19 patients. 15–17 According to recent studies, a novel combined biomarker of hemoglobin-albumin-lymphocyte-platelet (HALP) can reflect both systemic inflammation a -Abstract Truncated-
pharmacology & pharmacy,infectious diseases